ketoconazole

E850010

Ketoconazole is an imidazole antifungal medication that inhibits ergosterol synthesis and strongly blocks CYP3A4-mediated drug metabolism.

All labels observed (2)

Label Occurrences
ketoconazole canonical 5
Nizoral 1

How this entity was disambiguated

Statements (73)

Predicate Object
instanceOf antifungal drug ⓘ
azole antifungal ⓘ
imidazole derivative ⓘ
affects cytochrome P450–mediated drug metabolism ⓘ
canDecreaseSynthesisOf cortisol ⓘ
testosterone ⓘ
hasAdministrationNote oral systemic use has been largely restricted due to hepatotoxicity risk ⓘ
hasAdverseEffect abdominal pain ⓘ
elevated liver enzymes ⓘ
gynecomastia ⓘ
hepatotoxicity ⓘ
nausea ⓘ
pruritus ⓘ
rash ⓘ
vomiting ⓘ
hasATCCode D01AC08 ⓘ
G01AF11 ⓘ
J02AB02 ⓘ
hasBioavailability variable oral bioavailability ⓘ
hasBlackBoxWarningFor hepatotoxicity ⓘ
risk of severe liver injury ⓘ
hasBrandName Nizoral ⓘ
linked to: ketoconazole
hasCASNumber 65277-42-1 ⓘ
hasChemicalClass azole ⓘ
imidazole ⓘ
hasDosageForm cream ⓘ
foam ⓘ
gel ⓘ
shampoo ⓘ
tablet ⓘ
hasDrugInteractionMechanism CYP3A4 inhibition ⓘ
hasDrugInteractionWith cisapride ⓘ
dofetilide ⓘ
lovastatin ⓘ
midazolam ⓘ
pimozide ⓘ
quinidine ⓘ
simvastatin ⓘ
triazolam ⓘ
hasEliminationHalfLife approximately 2 to 8 hours ⓘ
hasMechanismOfAction inhibition of ergosterol synthesis ⓘ
hasMolarMass 531.43 g/mol ⓘ
hasMolecularFormula C26H28Cl2N4O4 ⓘ
hasOffLabelUse Cushing syndrome ⓘ
linked to: Cushing's disease

prostate cancer (hormonal therapy adjunct) ⓘ
hasPregnancyCategory C (US, historical) ⓘ
hasRouteOfAdministration oral ⓘ
topical ⓘ
inhibits CYP17A1 ⓘ
CYP3A4 ⓘ
ergosterol biosynthesis in fungi ⓘ
lanosterol 14α-demethylase ⓘ
isAcidDependentForAbsorption true ⓘ
isContraindicatedIn acute liver disease ⓘ
chronic liver disease ⓘ
isExcretedVia bile ⓘ
feces ⓘ
urine ⓘ
isHighlyProteinBound true ⓘ
isMetabolizedBy CYP3A4 ⓘ
liver ⓘ
isStrongInhibitorOf CYP3A4 ⓘ
targets lanosterol 14α-demethylase ⓘ
treats cutaneous candidiasis ⓘ
dandruff ⓘ
dermatophytosis ⓘ
pityriasis versicolor ⓘ
seborrheic dermatitis ⓘ
tinea corporis ⓘ
tinea cruris ⓘ
tinea pedis ⓘ
tinea versicolor ⓘ
wasFirstApprovedIn 1981 (US) ⓘ

How these facts were elicited

Referenced by (6)

Full triples — surface form annotated when it differs from this entity's canonical label.

CYP3A4 → inhibitedBy → ketoconazole ⓘ
CYP2J2 → inhibitedBy → ketoconazole ⓘ
ketoconazole → hasBrandName → Nizoral ⓘ
linked to: ketoconazole
Terfenadine → contraindicatedWith → ketoconazole ⓘ
subject linked to: terfenadine
Ebastine → hasDrugInteraction → ketoconazole ⓘ
subject linked to: ebastine
CYP2B6 → inhibitedBy → ketoconazole ⓘ